Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2012
04/19/2012WO2012049310A1 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
04/19/2012WO2012049301A1 Immunoadjuvant
04/19/2012WO2012049278A1 Therapies for improving pulmonary function
04/19/2012WO2012048817A2 Recombinant modified vaccinia virus ankara influenza vaccine
04/19/2012WO2012048553A1 Escherichia coli tolc antigen, antibody and use thereof
04/19/2012WO2012048430A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
04/19/2012WO2012024519A3 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
04/19/2012WO2012015270A3 Permissive cell line to the porcine reproductive and respiratory syndrome virus
04/19/2012WO2012010974A3 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
04/19/2012WO2012009288A9 Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
04/19/2012WO2012006376A3 Virion-like delivery particles for self-replicating rna molecules
04/19/2012WO2011163669A3 Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
04/19/2012WO2011163646A3 Methods for detection, diagnosis and selective eradication of neoplasms and circulating tumor cells using multidomain biotags
04/19/2012WO2011163308A3 Compositions and methods for preventing and treating organ injury and/or dysfunction
04/19/2012WO2011159976A3 Arthritis treatment
04/19/2012WO2011159938A3 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
04/19/2012WO2011159871A3 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
04/19/2012WO2011159655A3 IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
04/19/2012WO2011156774A3 Multivalent glycopeptide constructs and uses thereof
04/19/2012WO2011155705A3 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol
04/19/2012WO2011153397A3 Treatment of inflammatory disorders
04/19/2012WO2011150418A3 Compositions and methods for treating pathologies
04/19/2012WO2011150127A3 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
04/19/2012WO2011140284A3 Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
04/19/2012WO2011137354A3 Delivery proteins
04/19/2012WO2011137344A3 Anti-s1p antibody treatment of patients with ocular disease
04/19/2012WO2011126856A3 Herpes simplex virus mutant icp0
04/19/2012WO2011123826A3 Prevention and treatment of cast nephropathy
04/19/2012WO2011119920A9 Cmv glycoproteins and recombinant vectors
04/19/2012WO2011116094A3 Live attenuated chimeric porcine circovirus vaccine
04/19/2012WO2011094357A8 Respiratory virus epitopes templated into double stranded coiled -coils and use thereof in immunization
04/19/2012WO2011069074A3 Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1
04/19/2012WO2011031657A8 Use of an anti-il6 antibody to decrease hepcidin in cancer patients
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095558 Synthetic bone grafts constructed from carbon foam materials
04/19/2012US20120095439 Implantable therapeutic device
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120093936 Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
04/19/2012US20120093934 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
04/19/2012US20120093930 Article and method for focused delivery of therapeutic and/or diagnostic materials
04/19/2012US20120093921 Immunogenic compositions having low sodium chloride concentration
04/19/2012US20120093917 Metnase and intnase inhibitors and their use in treating cancer
04/19/2012US20120093914 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration
04/19/2012US20120093893 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
04/19/2012US20120093884 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012US20120093873 Molecular Interactions in Hematopoietic Cells
04/19/2012US20120093872 Method For Polypeptide Transfer Into Cells
04/19/2012US20120093871 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
04/19/2012US20120093870 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto
04/19/2012US20120093869 Live-attenuated compositions for bacterial infections
04/19/2012US20120093868 Haemophilus influenzae type b
04/19/2012US20120093867 GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis
04/19/2012US20120093866 Formulation for stabilizing proteins, which is free of mammalian excipient
04/19/2012US20120093865 Compositions comprising reduced genome bacteria for use in treatment of sepsis
04/19/2012US20120093864 Methods and Compositions for Polytopic Vaccination
04/19/2012US20120093863 Hcv vaccines and methods for using the same
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093861 Norovirus vaccine formulations
04/19/2012US20120093860 Influenza vaccines with increased amounts of h3 antigen
04/19/2012US20120093859 Influenza vaccine regimens for pandemic-associated strains
04/19/2012US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
04/19/2012US20120093857 Vaccination and Immunotherapy as New Therapeutic Modalities in the Treatment of Glaucoma
04/19/2012US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
04/19/2012US20120093855 RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF
04/19/2012US20120093854 Use of mycoplasma bovis antigen
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093852 Non-lipidated variants of neisseria meningitidis orf2086 antigens
04/19/2012US20120093851 Chlamydia antigens
04/19/2012US20120093850 Compositions for immunising against staphylococcus aureus
04/19/2012US20120093849 Agents for Treatment of HCV and Methods of Use
04/19/2012US20120093848 Immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
04/19/2012US20120093847 Recombinant rsv vaccines
04/19/2012US20120093846 Protein for the immunocastration for mammals
04/19/2012US20120093845 Neil3 peptides and vaccines including the same
04/19/2012US20120093843 Tem8 peptides and vaccines comprising the same
04/19/2012US20120093841 Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals
04/19/2012US20120093840 Targeted delivery of factor viii proteins to platelets
04/19/2012US20120093839 Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
04/19/2012US20120093838 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
04/19/2012US20120093837 Compositions and methods for detecting egfr in cancer
04/19/2012US20120093836 Pharmaceutical compositions for treating metastasis
04/19/2012US20120093835 Anti-inflammatory antibodies and uses therefor
04/19/2012US20120093834 Neutralizing molecules to viral antigens
04/19/2012US20120093833 Human Oncostatin M Antibodies and Methods of Use
04/19/2012US20120093832 Promotion of neuronal integration in neural stem cell grafts
04/19/2012US20120093831 Methods and materials for modulating resistance to apoptosis
04/19/2012US20120093830 Single domain antibodies that bind il-13
04/19/2012US20120093829 New methods for treatment of inflammatory diseases
04/19/2012US20120093828 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
04/19/2012US20120093827 Treatment of autoimmune disorders with a neurotoxin
04/19/2012US20120093826 Fully human antibodies specific to cadm1
04/19/2012US20120093825 Method for producing antibody using "naked" expression vector expressing type ii transmembrane fusion protein
04/19/2012US20120093824 Methods for treating pruritus by administering an antibody that specifically binds human par2
04/19/2012US20120093823 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
04/19/2012US20120093822 Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
04/19/2012US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
04/19/2012US20120093820 Prostatitis-Associated Antigens and Methods of Use Thereof
04/19/2012US20120093819 Antibodies that specifically block the biological activity of a tumor antigen
04/19/2012US20120093818 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
04/19/2012US20120093817 USE OF THE GENES IN THE HOG, Ras AND cAMP PATHWAY FOR TREATMENT OF FUNGAL INFECTION
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 1823